THOUGHT
LEADERSHIP
As a leading provider of services to Covered Entities participating in the 340B Drug
Pricing Program, Wellpartner is committed to identifying and analyzing all of the key
issues affecting the Program, and sharing our point of view with you. Being at the
forefront of change positions Wellpartner and our clients to positively influence the
future, as well as prepare for it.
340B Administrator SOC Compliance

340B Administrator SOC Compliance

Today, most businesses rely on third party experts/service providers to deliver critical services to their…

The 340B Drug Pricing Program Success Story: Ryan White HIV Entities

The 340B Drug Pricing Program Success Story: Ryan White HIV Entities

How government partnership with drug manufacturers and grassroots health organizations is changing lives, one patient…

Demystifying Pricing Methodologies Vendors Sell On Price, Partners Sell On Value

Demystifying Pricing Methodologies Vendors Sell on Price, Partners Sell on Value

Since the enactment of the Affordable Care Act in 2010, the 340B Drug Pricing Program…

Third Party Administration Opportunities For Covered Entities To Improve Oversight

Third Party Administration Opportunities for Covered Entities to Improve Oversight

The 340B industry has undergone significant changes since HRSA’s 2010 Contract Pharmacy Guidance, which paved…

The November Elections

The November Elections

Now is time for all Covered Entities participating in the 340B Drug Pricing Program –…

340B Aware And Beware

340B Aware and Beware

Being aware of the complex and ever-changing 340B Drug Pricing Program rules helps covered entities…